Nicotinamide adenine dinucleotide (NADH) may be utilized for the synthesis and regeneration of tetrahydrobiopterin (BH 4 ), which in turn is an essential cofactor for tyrosine hydroxylase, the rate-limiting enzyme in the synthesis of dopamine (DA). NADH has been reported to relieve some of the sympt
Effect ofl-tetrahydropalmatine on dopamine release and metabolism in the rat striatum
✍ Scribed by Françoise Marcenac; Guo Zhang Jin; François Gonon
- Publisher
- Springer
- Year
- 1986
- Tongue
- English
- Weight
- 538 KB
- Volume
- 89
- Category
- Article
- ISSN
- 0033-3158
No coin nor oath required. For personal study only.
✦ Synopsis
In vivo voltammetric measurements of striatal extracellular DOPAC concentrations and of striatal DA release in combination with post-mortem analysis of striatal catechols were performed in the rat to study the effects on the nigro-striatal neurons of a Chinese neuroleptic, ltetrahydropalmatine (/-THP), which is known to block post-synaptic dopaminergic receptors. /-THP injected at doses that cause sedation in rats and mice (5-10 mg/kg) induced a marked increase in post-mortem DOPAC levels (+ 250%), while no significant effect was observed on postmortem DA levels. The extracellular DOPAC concentration was increased to 155___9% of the control value after /-THP administration (1 mg/kg, IP). Further, an injection of/-THP (1 mg/kg, IP) induced an increase in extracellular DA concentration (220% of the basal value), reversed the decrease in extracellular DA concentration induced by apomorphine (0.05 mg/kg, SC) and enhanced the effects of the electrical stimulation of the nigro-striatal pathway. These results confirm that /-THP acts on the nigro-striatal neurons as a dopaminergic antagonist that can block both postand presynaptic receptors.
📜 SIMILAR VOLUMES
Striatal dopamine and its metabolites were studied in rats given lithium chloride in the diet. Results showed an increase in homovanillic acid and 3,4-dihydroxyphenylacetic acid levels but no significant change in dopamine concentration after 3 weeks of lithium administration. There was no change in